CALL FOR SPEAKER PROPOSALS
Cambridge Healthtech Institute is proud to announce its Second Annual Encouraging Development of Therapeutics for Neglected Diseases (April 4-5, 2011), co-located with the Third Annual Collaborative Innovations in Biomedicine (April 5-6, 2011) in Philadelphia, PA.
Neglected diseases are those for which there is no shortage of patients, but rather a shortfall in the ability of these patients to pay market rates for appropriate treatments. In recent years there has been a strong increase in funding and investment in the development of new therapeutics for these diseases, many of which are tropical infectious diseases.
The reasons why companies and researchers focus on developing treatments for these diseases are diverse, and there is a real need for better coordination and sharing of best practices in order to make investments as effective as possible. While much of the focus is on early efforts to identify new targets or identify new therapeutics for individual diseases, perhaps the greater challenge lies in the creation of a sustainable long-term framework. The cost of discovery projects can be low, whereas the cost and challenges of moving projects into later stage efforts to conduct clinical evaluations create the need for strong, objective methods for prioritization.
How can communication and collaboration be improved across this field, and particularly with those in less developed countries where the treatments are needed and must be implemented? What best practices can be shared, particularly with consortia and public-private partnerships, to help work in this vital field progress more rapidly and more effectively?
This meeting brings together experts from the range of segments participating in this field, including governmental, philanthropic, academic and commercial organizations, as well as consortia and partnerships. The goal is to present and discuss key developments and strategies, evaluate what is working well and what lessons have been learned, and to map out ideas for how best to improve results for developing, evaluating and implementing new therapeutics for neglected diseases.
Coverage Includes:
- Case studies of successful collaborations
- Drug repositioning projects applied to neglected diseases
- Engaging researchers and other stakeholders in developing countries
- The role of low cost diagnostics for neglected diseases
- Strategies for aggregating and supporting markets in developing countries
- Intellectual property challenges based on dual market strategy
- Networks for more efficient sharing of research results and resources
- Vaccines for prevention vs. treatment considerations
- Infrastructure for clinical evaluation and healthcare delivery in developing countries
- Evaluation of current funding opportunities and motivations
- Current progress and novel developments in ongoing research projects
If you would like be considered for giving a presentation at this meeting, please submit a presentation title and a brief (maximum of 60 words) summary of the topic you wish to cover. Priority will be given to higher level strategic issues over detailed technical coverage of a specific project. Feel free to suggest an additional topic that you think would add value to the conference.
All speaker proposals will be reviewed by our Advisory Committee.
Deadline for submission is October 8, 2010.
Register early and SAVE up to $300 off the standard rate.
For more details on the conference, please contact:
Margit Eder, Ph.D.
Conference Director
E:
P:
For partnering and sponsorship information, please contact:
Arnold Wolfson
Manager, Business Development
Cambridge Healthtech Institute
T: (+1)
E: